You are here:
Information Letter on Anticholium® (physostigmine salicylate): change in the approval
2020.05.14
Active substance: physostigmine salicylate
Dr. Franz Köhler Chemie GmbH informs about the change in the approval of Anticholium®. The intramuscular application is no longer approved. Anticholium® is now sodium metabisulfite free.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN